BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

9 articles for CW Andrews

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385.EBI
Glaxosmithkline
Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1.EBI
Glaxosmithkline
Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties.EBI
Glaxosmithkline
Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1.EBI
Glaxosmithkline
4-(Heteroarylthio)-2-biphenylyltetrazoles as nonpeptide angiotensin II antagonists.EBI
Burroughs Wellcome
COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITYBDB
Ifm Due
5H-pyrido[3,2-B]indole compounds as anticancer agentsBDB
Bristol-Myers Squibb
Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-C]quinolinesBDB
Bayer Intellectual Property
Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity relationship studies of PETT analogs.BDB
Eli Lilly